Key result
Doubled CD34+ progenitor cell counts linked to ~15% higher arterial stiffness and worse microvascular function.
Why the study?
The cross-sectional and longitudinal relationships between vascular function and circulating progenitor cell counts regarding aging and risk factor exposure remained to be investigated.
Is circulating progenitor cell count associated with vascular function and aging in adult participants?
Observational (n=797)
Is circulating progenitor cell count associated with vascular function and aging in adult participants?
Higher circulating progenitor cell counts are associated with better vascular function in younger individuals with risk factors, and lower baseline counts predict worsening vascular function over 2 years.
Higher CD34+ counts linked to worse vascular function; hypothesis-generating for compensatory mobilization amid age-risk interactions, needs prospective validation.
Background: To investigate the cross-sectional and longitudinal relationships between vascular function and circulating progenitor cell (CPC) counts with respect to aging and exposure to risk factors. Methods: In 797 adult participants, CPCs were enumerated by flow cytometry as CD45 med mononuclear cells expressing CD34 epitope and its subsets co-expressing CD133, and chemokine C-X-C motif receptor 4 (CXCR4+). Arterial stiffness was evaluated by tonometry-derived pulse wave velocity (PWV) and microvascular function was assessed as digital reactive hyperemia index (RHI). Results: In cross-sectional analyses, for every doubling in CD34+ cell counts, PWV was 15% higher and RHI was 9% lower, after adjusting for baseline characteristics and risk factors ( p for all < 0.01). There were significant CPC-by-age-by-risk factor interactions ( p <0.05) for both vascular measures. Among younger subjects (< 48 years), CPC counts were higher in those with risk factors and vascular function was better in those with higher compared to those with lower CPC counts ( p for all < 0.0l). In contrast, in older participants, CPCs were not higher in those with risk factors, and vascular function was worse compared to the younger age group. A lower CPC count at baseline was an independent predictor of worsening vascular function during 2-year follow-up. Conclusion: A higher CPC count in the presence of risk factors is associated with better vascular function among younger individuals. There is no increase in CPC count with risk factors in older individuals who have worse vascular function. Moreover, a higher CPC count is associated with less vascular dysfunction with aging.
No takes yet. Share an insight, caveat, or question.
Moazzami et al. (2022) reported an observational. Circulating progenitor cell (CPC) counts was evaluated on Arterial stiffness (pulse wave velocity) and microvascular function (reactive hyperemia index) (15% higher PWV, 9% lower RHI, p=< 0.01). For every doubling in CD34+ circulating progenitor cell counts, arterial stiffness (pulse wave velocity) was 15% higher and microvascular function (reactive hyperemia index) was 9% lower (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: